BMPR2 rs1085307151: Understanding Pulmonary Hypertension Risks
The rs1085307151 variant is a specific genetic alteration located within the BMPR2 gene. It is associated with a predisposition to primary pulmonary hypertension, a condition characterized by elevated blood pressure in the arteries that supply the lungs.
What each genotype means
Typical genetic profile
This genotype represents the common, non-pathogenic sequence at this position in the BMPR2 gene. It is not associated with the increased risk of primary pulmonary hypertension linked to this specific variant.
This is the most common genotype found in the general population.
Increased pulmonary hypertension risk
This genotype is associated with a predisposition to primary pulmonary arterial hypertension, a condition characterized by high blood pressure in the lung arteries. Because this condition has reduced penetrance, carrying this variant does not guarantee the development of the disease, and you should discuss any clinical concerns or family history with a healthcare provider or genetic counselor.
This specific genotype is rare in the general population.
Understanding the BMPR2 Gene
The BMPR2 gene provides instructions for making a protein called bone morphogenetic protein receptor type II. This protein is part of a signaling pathway that helps regulate cell growth and division, particularly in the cells that line the blood vessels of the lungs. When this gene functions correctly, it helps maintain the structure and function of the pulmonary arteries. However, when mutations occur in this gene, they can lead to a loss of receptor function. This disruption often results in the abnormal proliferation of smooth muscle and endothelial cells within the pulmonary vasculature, which can narrow the vessels and increase resistance to blood flow. This process is a central feature in the development of pulmonary arterial hypertension.
The Role of rs1085307151
The variant rs1085307151 is a specific change identified within the sequence of the BMPR2 gene. In the context of genetic research, variants in this gene are frequently studied because they are the most common genetic cause of heritable pulmonary arterial hypertension. Research indicates that pathogenic variants in BMPR2 can lead to haploinsufficiency, where the body does not produce enough functional protein to maintain normal vascular health. While many different mutations have been identified across the gene, rs1085307151 is categorized as a variant of interest due to its potential to disrupt the signaling pathways necessary for pulmonary vascular homeostasis. The evidence linking such variants to disease is considered moderate, as the clinical expression of these genetic changes can vary significantly between individuals.
Clinical Associations and Evidence
Scientific literature consistently identifies BMPR2 mutations as major contributors to both familial and sporadic cases of pulmonary arterial hypertension. Patients carrying pathogenic variants in this gene may experience an earlier onset of symptoms and more pronounced hemodynamic impairments compared to those without such variants. It is important to note that the presence of a variant does not guarantee the development of the disease, a concept known as incomplete penetrance. Factors such as other genetic modifiers, environmental triggers, and hormonal influences may play a role in whether an individual develops clinical symptoms. Because pulmonary arterial hypertension is a complex and progressive condition, genetic findings are typically used in conjunction with clinical assessments to understand a patient's risk profile.
Population Frequency and Interpretation
The rs1085307151 variant is classified as rare in the general population. Because it is not a common polymorphism, it is not typically found in large-scale population screening studies at high frequencies. The rarity of this variant means that our current understanding of its specific impact is based on limited clinical data. When interpreting genetic information, it is essential to recognize that rare variants require careful clinical correlation. If you have received information about this variant through genetic testing, it is recommended that you discuss the results with a genetic counselor or a specialist, such as a cardiologist or pulmonologist. They can provide context based on your personal and family medical history, which is crucial for understanding the clinical relevance of any genetic finding.
Managing Genetic Information
Genetic testing for variants like rs1085307151 can provide valuable insights for families with a history of pulmonary hypertension. However, this information should never be used to self-diagnose or make independent medical decisions. If you are concerned about your risk, consult with a healthcare professional who can order appropriate diagnostic tests, such as an echocardiogram or right heart catheterization, to assess your actual pulmonary artery pressure. Genetic counseling is highly recommended to help interpret these results, understand the implications for other family members, and discuss potential reproductive risks. Always rely on clinical evaluations and professional medical guidance rather than genetic data alone when managing your health.
How common is this variant?
The rs1085307151 variant is considered rare across all major global populations, with no significant frequency observed in standard reference databases.
Frequently asked questions
What is the link between BMPR2 and pulmonary hypertension?
Mutations in the BMPR2 gene are the most common genetic cause of pulmonary arterial hypertension. These mutations disrupt signaling pathways that regulate the growth of cells in the lung's blood vessels, leading to increased pressure.
Does having a BMPR2 variant mean I will get sick?
Not necessarily. Many people with BMPR2 variants never develop pulmonary hypertension, a phenomenon known as incomplete penetrance. Other genetic and environmental factors are likely required for the disease to manifest.
How is this variant detected?
This variant is typically identified through clinical genetic testing, such as targeted gene panels or whole-exome sequencing. These tests are usually ordered by a specialist after a clinical suspicion of pulmonary hypertension.
What should I do if I have this variant?
If you have been identified as a carrier, you should consult with a specialist, such as a pulmonologist or cardiologist. They can provide appropriate screening and monitoring based on your specific clinical situation.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1085307151?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in BMPR2
This pathogenic variant in the BMPR2 gene is linked to the development of primary pulmonary arterial hypertension.
This pathogenic variant in the BMPR2 gene is associated with an increased risk of developing primary pulmonary hypertension.